SENSE Study

SENSE: A Study to Evaluate the relationship between Novel interstitial, real-time Glucose SEnsors and reference glucose values in people with diabetes mellitus?

SAVA Technologies are developing 2 new wearable biosensors which will be used to calculate the blood glucose (sugar) levels in people with type 1 or type 2 diabetes who use insulin.

Status: Open to recruitment.

To join this research study, you must:

• Be aged 18 years or older
• Have diabetes
• Use insulin injections to manage your diabetes

Location: Cambridge Clinical Research Centre on Keith Day Road, next to the Addenbrooke’s Treatment Centre, and part of the Cambridge Biomedical Centre.

Find out more
Email: Jane Kennet